AIDS News and Research

RSS

PhRMA reports 100 new medicines and vaccines in development for HIV/AIDS

America's biopharmaceutical research companies are working on 100 new medicines and vaccines [video] to treat and prevent HIV/AIDS and related conditions, according to a new report from the Pharmaceutical Research and Manufacturers of America (PhRMA).

1 Dec 2010

Number of people living with HIV/AIDS in Africa to outpace treatment resources by 2020, IOM report finds

The number of people living with HIV/AIDS in Africa is projected to greatly outpace treatment resources by the end of the decade, according to a report released Monday by the Institute of Medicine (IOM), Reuters reports (Fox, 11/29).

1 Dec 2010

Goosby, Emanuel address progress, potential roadblocks ahead for introduction of microbicides in developing countries

The growing evidence supporting the promise of new HIV prevention products, like microbicides, requires that groups start planning now for how best to roll-out prevention interventions in the future, U.S. Global AIDS Coordinator Eric Goosby and Special Advisor on Health Policy to the Director of the White House Office of Management and Budget Ezekiel Emanuel said Monday during a USAID Microbicide Stakeholders Meeting in Washington.

30 Nov 2010

Opinions: Obama's Global Fund pledge; harm reduction in Iran; HIV prevention; African development

There are some encouraging signs in the epic battle against AIDS and HIV infections. But those bright spots dim considerably in the face of the fact that about 7,100 people a day become infected.

30 Nov 2010

HIV testing rates rise among Americans

A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.

30 Nov 2010

Total Immersion adds Vantage Surgical Systems to North American AR Partner network

Total Immersion, the global leader in augmented reality (AR), today announced the addition of Vantage Surgical Systems as a Certified D'Fusion Value Added Reseller to its North American Partner network, the world's largest network dedicated to AR.

30 Nov 2010

AIDS Healthcare Foundation to participate in Members Project

AIDS Healthcare Foundation (AHF) is proud to be selected as a candidate charity in Members Project, a partnership between American Express and TakePart.

30 Nov 2010

HP, Clinton Health Access Initiative collaborate to improve HIV testing and treatment of infants in Kenya

HP today announced an alliance with the Clinton Health Access Initiative (CHAI) that will provide structural and systemic improvements in testing and treating more than 120,000 infants exposed to HIV in Kenya each year.

30 Nov 2010

GeoVax supports Bionor's Phase 2b trial of therapeutic HIV/AIDS vaccine

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for HIV/AIDS (HIV-1, Human Immunodeficiency Virus), announced it was pleased to learn of the partial success observed in the recently completed Phase 2b trial of a therapeutic HIV/AIDS vaccine produced by Bionor Immuno AS of Oslo, Norway.

30 Nov 2010

International Harm Reduction Conference to focus on HIV/AIDS epidemic

Injecting drug use and growing HIV/AIDS epidemic in Middle East and North Africa region to be focus of the International Harm Reduction conference taking place in Beirut, Lebanon April 3-7 2011

30 Nov 2010

Washington Post examines development experts' reactions to draft QDDR

The Washington Post examines development experts' "mixed reactions" to the recent roll out of the State Department's draft Quadrennial Diplomacy and Development Review (QDDR), which would give USAID "a bigger role in running President [Barack] Obama's two main foreign aid initiatives - health and agriculture."

30 Nov 2010

To reduce spread of HIV/AIDS, IFRC calls for more focus on IDU programs

Ahead of World AIDS Day, the International Federation of the Red Cross on Friday released a report (.pdf) calling for governments around the world to do more to help stop the spread of HIV/AIDS among populations of injecting drug users (IDUs), the Associated Press reports (Heilprin, 11/25).

30 Nov 2010

USPTO awards Immunitor key patent for viral vaccine

Immune Network Ltd., advises that its potential acquisition, Immunitor USA Inc., has been issued a key patent by the U.S. Patent and Trademark Office (USPTO).

29 Nov 2010

New 'canSAR' cancer drug discovery database launched

A powerful new cancer drug discovery database has been launched to speed up the process of bringing drugs from 'bench to bedside'.

29 Nov 2010

Unique collaboration results in new bandage splint for hip surgery patients

The new splint can reduce the need for large external support structures to fixate the hip following hip surgery. The secret behind the fast development is collaboration between a research scientist, an enterprise and a full-time student using this case for her bachelor project.

25 Nov 2010

WHO/UN-HABITAT report documents health disparities facing women in developing country urban areas

Womens News Network/Guardian Development Network examines a WHO/United Nations Human Settlements Programme report released last week that highlighted the health disparities affecting populations living in urban areas.

25 Nov 2010

How HIV kills CD4 T cells

Researchers appear to have an explanation for a longstanding question in HIV biology: how it is that the virus kills so many CD4 T cells, despite the fact that most of them appear to be "bystander" cells that are themselves not productively infected. That loss of CD4 T cells marks the progression from HIV infection to full-blown AIDS, explain the researchers who report their findings in studies of human tonsils and spleens in the November 24th issue of Cell, a Cell Press publication.

25 Nov 2010

Media outlets continue to follow major HIV/AIDS developments this week

Media outlets continued to track the major developments in HIV/AIDS this week, including: prevention research using an antiretroviral; new UNAIDS estimates of HIV/AIDS around the world; and Pope Benedict XVI's stance on condoms for HIV prevention.

25 Nov 2010

New drug research, incidence rates and Pope's comments brighten AIDS outlook

The Associated Press: "In the nearly 30 years the AIDS epidemic has raged, there has never been a more hopeful day than this. Three striking developments took place Tuesday: U.N. officials said new HIV cases are dropping dramatically worldwide. A study showed that a daily pill already on pharmacy shelves could help prevent new infections in gay men. And the pope opened the way for the use of condoms to prevent AIDS" (Marchione, 11/23).

25 Nov 2010

Scientists reveal long-standing mystery about HIV infection

Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection-namely how HIV promotes the death of CD4 T cells.

25 Nov 2010